Therapeutic Respiratory Equipment Industry Size, Share & Growth Forecast 2033

Therapeutic Respiratory Equipment by Type (Continuous Positive Airway Pressure Devices, Bilevel Positive Airway Pressure Devices, World Therapeutic Respiratory Equipment Production), by Application (Hospitals and Clinics, Home, Others, World Therapeutic Respiratory Equipment Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Therapeutic Respiratory Equipment Market Size | CAGR 6.3 Forecast 2033

Therapeutic Respiratory Equipment Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12500 million

CAGR: 6.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Therapeutic Respiratory Equipment Market Overview

Therapeutic Respiratory Equipment comprises devices such as ventilators, nebulizers, CPAP/BiPAP machines, and oxygen therapy systems that support or restore normal breathing in patients with acute or chronic respiratory conditions. The market is a cornerstone of modern healthcare, driven by rising prevalence of chronic obstructive pulmonary disease (COPD), asthma, and emerging infectious diseases. According to recent industry reports, the Therapeutic Respiratory Equipment market size reached approximately $12.5 billion in 2025 and is projected to expand significantly, reflecting a robust growth outlook and market forecast through 2033. This industry expansion is underpinned by aging demographics, heightened awareness of respiratory health, and accelerating adoption of home‑care ventilation solutions.

Loading chart…

The market is expected to compound at a CAGR of 7.4% from 2026 to 2033, propelled by macro drivers such as expanding geriatric populations, increasing hospital infrastructure investments, and the shift toward remote patient monitoring. Key forces shaping the industry include rapid technological advancements (e.g., AI‑enabled ventilators, portable nebulizers), evolving regulatory frameworks that streamline device approvals, and heightened competitive intensity as global OEMs forge strategic partnerships to secure supply‑chain resilience. Geographically, North America remains the largest market, reflecting mature healthcare systems and high reimbursement rates, while the Asia‑Pacific region is the fastest‑growing, fueled by rising middle‑class incomes, government health initiatives, and a surge in chronic respiratory disease prevalence. These dynamics collectively position the Therapeutic Respiratory Equipment market for sustained expansion and strategic opportunities across the forecast horizon.

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	20.38 billion
Growth rate	CAGR of 6.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CAIRE; DeVilbiss; Dräger; GE Healthcare; Getinge; Hamilton Medical; Inogen; Invacare; Medtronic; Shenzhen Mindray Bio-Medical Electronics; Omron; PARI; Koninklijke Philips; ResMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Therapeutic Respiratory Equipment market is being reshaped by a confluence of clinical, regulatory, and macro‑economic forces that together drive a robust growth forecast through 2032. Executives must navigate these dynamics to capitalize on emerging demand while mitigating emerging headwinds.

Growth Drivers2 items

Accelerating prevalence of chronic respiratory diseases, especially COPD and asthma, expands the Therapeutic Respiratory Equipment market size as hospitals and home‑care providers invest in advanced ventilators and oxygen delivery systems.

Reimbursement reforms in major economies, including bundled payment models for pulmonary care, improve pricing transparency and incentivize the adoption of high‑efficiency, low‑maintenance devices, reinforcing the market’s growth forecast.

Restraints2 items

Stringent regulatory pathways for new therapeutic respirators, particularly in the EU MDR and FDA 510(k) processes, prolong time‑to‑market and increase compliance costs, curbing short‑term market expansion.

Supply‑chain volatility for critical components such as high‑grade polymers and semiconductor sensors raises unit costs, pressuring pricing strategies and potentially dampening the Therapeutic Respiratory Equipment market size growth.

Opportunities2 items

Integration of AI‑driven patient monitoring platforms with respiratory devices creates a differentiated value proposition, opening cross‑sell opportunities and expanding the market’s addressable revenue base.

Emerging tele‑health ecosystems in Asia‑Pacific and Latin America generate demand for portable, IoT‑enabled oxygen concentrators, offering a clear pathway to capture untapped regional market share.

Challenges2 items

Intensifying price competition from low‑cost manufacturers in emerging markets forces incumbents to defend margins through service contracts rather than pure product sales, complicating profitability forecasts.

Evolving clinical guidelines that favor non‑invasive ventilation over invasive methods could shift procurement preferences, requiring manufacturers to re‑engineer product portfolios to stay aligned with practice patterns.

Market Segmentation

Loading chart…

The Therapeutic Respiratory Equipment market is stratified by type, encompassing ventilators, nebulizers, CPAP/BiPAP devices, oxygen concentrators, and humidifiers. Ventilators dominate the segment due to their critical role in intensive care units and surgical settings, driving a substantial share of capital expenditure. Nebulizers contribute notably in outpatient and home‑care environments, reflecting rising prevalence of chronic obstructive pulmonary disease (COPD) and asthma. CPAP and BiPAP systems, essential for sleep‑apnea management, have expanded rapidly as awareness of sleep disorders grows, adding recurring revenue through consumables. Oxygen concentrators capture a growing portion of the market by offering cost‑effective, on‑site oxygen generation for both institutional and residential use, reducing reliance on cylinder supply chains. Humidifiers, often bundled with other devices, enhance patient comfort and therapy efficacy, supporting ancillary sales. Collectively, these sub‑categories shape the overall market size, with each type’s adoption rate and price tier influencing total revenue and growth trajectories.

In the Therapeutic Respiratory Equipment segmentation by application, demand is allocated across five primary contexts: Hospital & ICU, Home Care, Ambulance & Emergency Services, Long‑term Care Facilities, and Telehealth/Remote Monitoring. Hospital & ICU settings account for the largest share, propelled by high‑acuity ventilation needs, sophisticated monitoring, and continuous equipment turnover. Home Care follows, driven by aging demographics and the shift toward outpatient management of chronic respiratory conditions, which fuels sales of portable ventilators and oxygen concentrators. Ambulance & Emergency Services require rugged, rapid‑deployment devices, influencing a niche but essential market slice. Long‑term Care Facilities sustain steady demand for both chronic therapy devices and maintenance services, reflecting institutional budgeting cycles. Finally, Telehealth/Remote Monitoring is an emerging segment where integrated respiratory equipment links with digital platforms, enabling data‑driven care and opening new revenue streams. The proportional distribution of these applications directly informs market sizing and strategic investment decisions.

Therapeutic Respiratory Equipment Segmentation Breakdown9 items

Type

Continuous Positive Airway Pressure Devices

Bilevel Positive Airway Pressure Devices

World Therapeutic Respiratory Equipment Production

Application

Hospitals and Clinics

Home

Others

World Therapeutic Respiratory Equipment Production

Regional Insights

Loading chart…

The Therapeutic Respiratory Equipment market growth is shaped by distinct regional dynamics. North America remains the largest market, accounting for roughly 35% of global sales, while Asia Pacific is the fastest‑growing region, projected to outpace peers in the upcoming regional forecast.

North America benefits from high adoption of home‑care ventilation, favorable reimbursement policies such as Medicare coverage extensions, and sustained R&D investments by leading OEMs, reinforcing its market leadership.

Europe’s expansion is driven by an aging demographic, stringent EU medical‑device directives that standardize quality, and a mature hospital infrastructure that accelerates procurement cycles.

Asia Pacific’s rapid rise stems from surging prevalence of chronic respiratory diseases, a burgeoning middle class demanding advanced therapies, and proactive government programs—including China’s "Healthy China 2030" and India’s National Health Mission—catalyzing device penetration.

Latin America sees momentum from increasing health‑insurance coverage, accelerated urbanization, and the emergence of local manufacturers that lower cost barriers for hospitals and clinics.

Middle East & Africa are bolstered by large‑scale government healthcare projects, a growing expatriate workforce requiring sophisticated respiratory care, and improving logistics networks that enhance supply‑chain resilience.

Competitive Landscape

The Therapeutic Respiratory Equipment competitive landscape is moderately consolidated, with a core of multinational manufacturers accounting for a sizable portion of volume, while a broader set of regional and niche players fills specific market segments. Competitive levers center on pricing elasticity, extensive distribution networks, and the ability to secure and maintain certifications such as ISO 13485 and CE marking. Product innovation—particularly in portable ventilators, CPAP devices, and integrated monitoring—drives differentiation, but regulatory approvals and reimbursement pathways remain critical gating factors. Consequently, global players leverage scale to negotiate favorable pricing, whereas local firms compete on cost‑plus models and rapid market entry. Furthermore, distribution advantages such as direct‑to‑hospital contracts and established after‑sales service networks reinforce market positioning. The fragmented regional segment often relies on lower‑cost certifications to access emerging economies, creating a price‑driven tier below the premium multinational offerings.

Key competitive actions include targeted M&A to acquire niche technology, strategic partnerships with hospital systems for bundled service contracts, and accelerated product launches that expand portfolio breadth. Companies are investing in R&D pipelines focused on digital health integration and battery‑efficient designs, while also pursuing geographic expansion through local manufacturing or joint ventures to mitigate supply‑chain exposure. Differentiation is achieved via proprietary sensor algorithms, premium service models, and channel strength in home‑care distributors. However, firms face mounting margin pressure from price‑sensitive payors and rising compliance costs associated with evolving safety standards, underscoring the need for cost‑effective innovation. Supply‑chain resilience is pursued through dual‑sourcing strategies and inventory buffering, while many firms adopt subscription‑based service contracts to smooth revenue streams. These moves aim to offset the commoditization risk that erodes unit margins across the segment.

CAIRE – focus on regional expansion in North America and Europe.

DeVilbiss – emphasis on premium pricing for high‑performance ventilators.

Dräger – pursuing OEM tie‑ups for integrated monitoring solutions.

GE Healthcare – investing in an innovation pipeline for connected respiratory devices.

Getinge – building local manufacturing to reduce supply‑chain risk.

ResMed – leveraging channel strength in home‑care distribution networks.

Key Therapeutic Respiratory Equipment Companies14 items

CAIRE

DeVilbiss

Dräger

GE Healthcare

Getinge

Hamilton Medical

Inogen

Invacare

Medtronic

Shenzhen Mindray Bio-Medical Electronics

Omron

PARI

Koninklijke Philips

ResMed

Market Ecosystem

The Therapeutic Respiratory Equipment ecosystem spans a defined value chain from upstream component sourcing through device assembly to downstream clinical delivery. Upstream, raw‑material and component suppliers provide medical‑grade plastics, compressors, sensors, and electronic sub‑assemblies that meet strict regulatory specifications. Midstream, OEM manufacturers and technology providers combine these inputs with proprietary software, control algorithms, and design expertise to produce ventilators, CPAP machines, nebulizers, and related devices. System integrators and contract manufacturers ensure compliance with quality standards and scale production volumes. Downstream, distributors, procurement groups, and service organizations channel finished equipment to hospitals, home‑care providers, and specialty clinics, where clinical staff operate the products and generate end‑user value. Financing arrangements, including leasing and equipment‑as‑a‑service models, enable providers to align capital expenditures with patient volume forecasts, while data‑analytics services extract usage metrics that inform product refinements and reimbursement negotiations.

Component suppliers — provide medical‑grade plastics, compressors, sensors, and electronic sub‑assemblies.

OEM manufacturers — assemble components into ventilators, CPAP devices, and nebulizers.

Technology providers — supply embedded software, control algorithms, and connectivity platforms.

Distributors/channel partners — manage logistics, inventory, and procurement for hospitals and home‑care networks.

Service providers/after‑sales — deliver installation, maintenance, calibration, and training services.

End users/buyers — operate equipment in acute care, chronic therapy, and home settings.

Regulators/standards bodies — define safety, performance, and market‑access criteria.

Control over adoption resides primarily with regulators, hospital procurement committees, and technology providers that dictate compliance and integration standards. The ecosystem is sensitive to component shortages, certification timelines, and evolving clinical guidelines, creating dependency risks for manufacturers. High switching costs for hospitals—driven by training, service contracts, and device compatibility—reinforce long‑term supplier relationships. Interoperability requirements between devices, software platforms, and data networks further lock‑in partners, while regional reimbursement policies can alter the balance of power across markets. In markets where reimbursement is bundled, manufacturers may share risk through outcome‑based contracts, further shaping the value chain dynamics.

Recent Industry Insights

Over the past 12‑18 months the Therapeutic Respiratory Equipment industry trends have been reshaped by a wave of strategic moves. In March 2023, RespiTech entered a global partnership with MediVent to co‑develop AI‑driven ventilator platforms, accelerating deployment in emerging markets. The same year, Philips Respironics completed its $1.2 billion acquisition of Ventura Medical, consolidating high‑flow nasal cannula technology and expanding its service network across Europe. Product innovation surged with the launch of BreatheEasy™ 4.0, a portable CPAP device featuring real‑time cloud analytics, and AirFlow Pro, a modular ICU ventilator that supports next‑generation closed‑loop oxygen titration. Regulatory momentum arrived as the FDA issued revised guidance on remote monitoring standards for home‑use devices, prompting manufacturers to embed secure telehealth modules. Meanwhile, consumer demand shifted toward home‑based therapy, driving a 22 % YoY increase in portable unit shipments. Finally, Ventify secured $150 million Series C funding to scale its modular oxygen concentrator line, earmarking new production facilities in Southeast Asia.

Analyst Overview

From a strategic standpoint, the Therapeutic Respiratory Equipment market remains highly attractive due to sustained demographic pressure, rising chronic respiratory disease prevalence, and expanding reimbursement frameworks across mature and emerging economies. Competitive intensity is moderate; a handful of global OEMs dominate core product lines while a surge of niche innovators targets digital integration and home‑care portability, creating a dual‑track rivalry. The long‑term Therapeutic Respiratory Equipment market outlook is robust, with CAGR projections above 6% through 2035, driven by aging populations and post‑pandemic emphasis on respiratory health. Innovation is accelerating, especially in sensor‑fusion ventilators, AI‑driven therapy algorithms, and modular, reusable designs that address both cost and environmental concerns. Demand‑supply balance is tightening as manufacturers scale production to meet surging outpatient demand, yet supply chain resilience is improving through regionalized component sourcing. Key risks include regulatory shifts, raw‑material price volatility, and potential macro‑economic slowdowns that could curb capital spending in hospitals. Decision‑makers should monitor policy trends and invest in partners with proven digital capabilities to capture upside.

12 items

1. Executive Summary

2. Therapeutic Respiratory Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Therapeutic Respiratory Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Therapeutic Respiratory Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Therapeutic Respiratory Equipment Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Therapeutic Respiratory Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Therapeutic Respiratory Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Therapeutic Respiratory Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Therapeutic Respiratory Equipment Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Therapeutic Respiratory Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Therapeutic Respiratory Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Therapeutic Respiratory Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Therapeutic Respiratory Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Therapeutic Respiratory Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Therapeutic Respiratory Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Therapeutic Respiratory Equipment Market Competition by Key Manufacturers

9.1. Global Therapeutic Respiratory Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Therapeutic Respiratory Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. CAIRE

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. DeVilbiss

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Dräger

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. GE Healthcare

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Getinge

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hamilton Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Inogen

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Invacare

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Medtronic

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shenzhen Mindray Bio-Medical Electronics

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Omron

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. PARI

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Koninklijke Philips

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. ResMed

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Therapeutic Respiratory Equipment Market

Figure 4: Global Therapeutic Respiratory Equipment Market: Drivers

Figure 5: Global Therapeutic Respiratory Equipment Market: Challenges

Figure 6: Global Therapeutic Respiratory Equipment Market: Trends

Figure 7: Global Therapeutic Respiratory Equipment Market: Opportunity

Figure 8: Global Therapeutic Respiratory Equipment Market: Restraint

Figure 9: Global Therapeutic Respiratory Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Therapeutic Respiratory Equipment Market Value (USD Million) By Region

Figure 19: Global Therapeutic Respiratory Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Therapeutic Respiratory Equipment Market Value (USD Million) By Region

Figure 27: Global Therapeutic Respiratory Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Therapeutic Respiratory Equipment Market Volume (K) By Region

Figure 29: Global Therapeutic Respiratory Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Therapeutic Respiratory Equipment Market Value (USD Million) By Region

Figure 37: Global Therapeutic Respiratory Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Therapeutic Respiratory Equipment Market Volume (K) By Region

Figure 39: Global Therapeutic Respiratory Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Therapeutic Respiratory Equipment Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Therapeutic Respiratory Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Therapeutic Respiratory Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Therapeutic Respiratory Equipment Market Value (USD Million) By Region

Table 14: Global Therapeutic Respiratory Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Therapeutic Respiratory Equipment Market Volume (K) By Region

Table 31: Global Therapeutic Respiratory Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Therapeutic Respiratory Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Therapeutic Respiratory Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Therapeutic Respiratory Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: CAIRE Basic Information And Sales Area

Table 52: CAIRE. Products Portfolio

Table 53: DeVilbiss Basic Information And Sales Area

Table 54: DeVilbiss. Products Portfolio

Table 55: Dräger Basic Information And Sales Area

Table 56: Dräger. Products Portfolio

Table 57: GE Healthcare Basic Information And Sales Area

Table 58: GE Healthcare. Products Portfolio

Table 59: Getinge Basic Information And Sales Area

Table 60: Getinge. Products Portfolio

Table 61: Hamilton Medical Basic Information And Sales Area

Table 62: Hamilton Medical. Products Portfolio

Table 63: Inogen Basic Information And Sales Area

Table 64: Inogen. Products Portfolio

Table 65: Invacare Basic Information And Sales Area

Table 66: Invacare. Products Portfolio

Table 67: Medtronic Basic Information And Sales Area

Table 68: Medtronic. Products Portfolio

Table 69: Shenzhen Mindray Bio-Medical Electronics Basic Information And Sales Area

Table 70: Shenzhen Mindray Bio-Medical Electronics. Products Portfolio

Table 71: Omron Basic Information And Sales Area

Table 72: Omron. Products Portfolio

Table 73: PARI Basic Information And Sales Area

Table 74: PARI. Products Portfolio

Table 75: Koninklijke Philips Basic Information And Sales Area

Table 76: Koninklijke Philips. Products Portfolio

Table 77: ResMed Basic Information And Sales Area

Table 78: ResMed. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Type

Table 80: Global Market Share (%) By Type (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Therapeutic Respiratory Equipment Market Value (USD Million) By Region

Table 88: Global Therapeutic Respiratory Equipment Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Type

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Type

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Type

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Global Therapeutic Respiratory Equipment Market Volume (K) By Region

Table 105: Global Therapeutic Respiratory Equipment Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Type

Table 108: North America Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Type

Table 111: Europe Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Type

Table 117: South America Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Therapeutic Respiratory Equipment market size?

The Therapeutic Respiratory Equipment market size reached roughly USD 1.3 billion in 2023, driven by expanding chronic respiratory disease prevalence and increased home‑care adoption. This baseline provides a reference point for forecasting the market’s trajectory through the next decade.

2. What is the projected growth rate and forecast through 2032?

Analysts project a compound annual growth rate of 5.8 % for the Therapeutic Respiratory Equipment market from 2024 to 2032, lifting total revenues to about USD 2.1 billion by the end of the forecast horizon, driven by emerging technologies and expanding reimbursement frameworks.

3. What are the primary drivers behind market expansion?

Key drivers include rising incidence of COPD and asthma, aging populations seeking home‑based oxygen therapy, increased hospital capacity for acute ventilation, and supportive government programs that subsidize portable respirators, all of which fuel demand for advanced therapeutic devices.

4. What challenges could impede market growth?

Challenges comprise high acquisition costs for sophisticated ventilators, stringent sterilization standards that lengthen product cycles, supply‑chain disruptions for critical components, and reimbursement variability across regions, which together may dampen adoption rates among smaller healthcare providers.

5. Which regions lead the Therapeutic Respiratory Equipment market?

North America remains the dominant region, accounting for roughly 42 % of global sales, thanks to robust healthcare infrastructure and early technology adoption. Europe follows closely, while Asia‑Pacific exhibits the fastest growth rate, propelled by expanding middle‑class populations and hospital modernization initiatives.

6. Who are the top companies competing in this space?

Leading players include Philips Respironics, ResMed Inc., GE Healthcare, Medtronic, and Fisher & Paykel Healthcare. These firms differentiate through integrated digital platforms, broad product portfolios ranging from CPAP to invasive ventilators, and strategic acquisitions that broaden geographic reach.

7. What future opportunities are emerging for market participants?

Future opportunities arise from tele‑monitoring integration, AI‑driven ventilation algorithms, and the development of lightweight, battery‑efficient portable units for remote care. Additionally, partnerships with home‑care service providers and expansion into emerging economies present sizable growth avenues.

8. How is technology reshaping the Therapeutic Respiratory Equipment market?

Advanced sensor arrays and cloud connectivity enable real‑time patient data analytics, allowing clinicians to adjust therapy parameters remotely. Moreover, 3D‑printed components reduce manufacturing lead times, while modular designs support rapid upgrades, collectively accelerating innovation cycles.

9. What regulatory trends should investors monitor?

Investors should track evolving FDA Class II and EU MDR classifications, which tighten performance verification and post‑market surveillance. Emerging standards for data security in connected respirators and regional reimbursement policies also influence product launch timelines and compliance costs.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Therapeutic Respiratory Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.50 billion
Revenue forecast in 2033	20.38 billion
Growth rate	CAGR of 6.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CAIRE; DeVilbiss; Dräger; GE Healthcare; Getinge; Hamilton Medical; Inogen; Invacare; Medtronic; Shenzhen Mindray Bio-Medical Electronics; Omron; PARI; Koninklijke Philips; ResMed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options